EU Court gives the go ahead on certain stem cells – Olivia Hart

22 December 2014 by

parthenote-stemcellInternational Stem Cell Corporation v Comptroller General of Patents [2014] EUECJ C-364-13, 18 December 2014 – read judgment 

This was a referral to the European Court of Justice (CJEU) requesting clarification of Article 6(2) of Directive 98/44/EC protecting biotechnological inventions (“the Biotech Directive”). We posted earlier about the High Court decision leading up to the referral concerning two GB patent applications that both involve the ‘parthenogenetic activation of oocytes’. The Court asked for clarification on what exactly defines a human embryo and what precisely is the developmental potential of a parthenote

Ever since scientists came upon the idea of using embryonic stem cells for therapeutic purposes there has been a something of an ethical furore around the topic. So the pressure has been on to find alternatives. Parthenotes – products of unfertilised egg division – have been proposed as candidates. However even research using parthenotes may fall foul of the law’s protection of ‘human dignity’. 


Human embryonic stem cells are cells that have are derived from the inner cell mass of a blastocyst (an early form of an embryo). These cells can divide and proliferate indefinitely and can be induced to differentiate into any type of cell in the human body (red blood cells, epidermal cell, hepatic cell etc). We have already seen the therapeutic value of cells with the potential for curing any human defect or disease ranging from diabetes to paralysis. The problem is that these stem cells are derived from terminated embryos. This goes against many religious, social and cultural ways of thinking and therein here lies the problem.

The word parthenote originates from the term ‘parthenogenesis’ which describes the growth and development of an embryo without fertilisation. In the natural world this most commonly happens in asexual organisms. These organisms do not require a second gamete (sperm) to fertilise and stimulate the growth of the embryo. Instead the embryo grows and contains only one set of chromosomes. This of course does not occur naturally in humans. Without external manipulation the human ovum cannot grow and develop into a zygote without fertilisation from a sperm. In vitro however, parthenogenesis can be induced. This is done by mimicking the chemical imbalance caused by sperm at the point of fertilisation. If this imbalance is successfully simulated then the oocyte will be stimulated to divide. These are called parthenotes.

These parthenotes can be induced to develop to various different stages, but never to term. In humans these parthenotes never surpass the blastocyst stage. However, strictly speaking, the term blastocyst is not correct. A blastocyst is the precursor to the embryo, both of with are a mass of fertilised cells. The parthenotes have not been fertilised; they have merely been stimulated to act in similar way to fertilised cells.

The Court’s decision

According to the Biotech Directive the human embryo is unpatentable for two principal reasons.

Under EU law, a patent defines a process or concept that is a new invention or that which involves an inventive step. In the case of biotechnology this means that the process, item or material may involve natural biological materials but it must involve a technical process that has been designed by the applicant. Therefore the simple discovery of any biological material cannot be described as inventive and is therefore non-patentable. This arises from Directive 98/44 Article 3

Biological material which is isolated from its natural environment or produced by means of a technical process may be the subject of an invention even if it previously occurred in nature.

and Article 5(1) and (2)

The human body, at the various stages of its formation and development, and the simple discovery of one of its elements, including the sequence or partial sequence of a gene, cannot constitute patentable inventions.

The second reason is that the patenting of the human embryo relates to the use of the human body as a commodity and infringes the integrity of the person. This also relates to the ethical issues that are implicated when considering human embryos and embryonic stem cells and the potential offence this commodification may cause.

Article 16 in the preamble to Directive 98/44

Whereas patent law must be applied so as to respect the fundamental principles safeguarding the dignity and integrity of the person;

Article 37 in the preamble to Directive 98/44

Whereas the principle whereby inventions must be excluded from patentability where their commercial exploitation offends against ordre public or morality must also be stressed in this Directive 

The distinction in the present case arises out of the classification of a human embryo. An embryo is a collection of diploid cells – diploid indicating that two sets of chromosomes are contained within each cells nucleus. Therefore a parthenote derived from a human oocyte is not an embryo because it contains only a single set of DNA. Therefore, all mention of the human embryo in the directive is irrelevant to the current application.

There are other reasons why parthenotes are not unpatentable under the Directive.

  1. Human parthenotes are not naturally occurring; they are created in the laboratory through stimulation using technical means. Therefore, they can be an invention using biological materials, created by a clear technical process.
  2. Parthenotes are unable to develop into a human being; they lack the paternal DNA. As a result they do not fly in the face of fundamental principles safeguarding the dignity and integrity of the person and do not offend against the ordre public or morality. This is to say that while parthenotes initially divide and grow in a way that is similar to a human embryo, the manipulation and premature termination of their growth could never be classed as the prevention of a human life.

Hence, the court concluded that an ovum stimulated to divide by parthenogenesis does not constitute it to be a human embryo. So parthenotes are patentable.

Olivia Hart is a postgraduate student of Biotechnology at the University of Warwick

Sign up to free human rights updates by email, Facebook, Twitter or RSS

Related posts:

Welcome to the UKHRB

This blog is run by 1 Crown Office Row barristers' chambers. Subscribe for free updates here. The blog's editorial team is:
Commissioning Editor: Jonathan Metzer
Editorial Team: Rosalind English
Angus McCullough QC David Hart QC
Martin Downs
Jim Duffy

Free email updates

Enter your email address to subscribe to this blog for free and receive weekly notifications of new posts by email.




Aarhus Abortion Abu Qatada Abuse Access to justice adoption AI air pollution air travel ALBA Allergy Al Qaeda Amnesty International animal rights Animals Anne Sacoolas anonymity Article 1 Protocol 1 Article 2 article 3 Article 4 article 5 Article 6 Article 8 Article 9 article 10 Article 11 article 13 Article 14 article 263 TFEU Artificial Intelligence Asbestos Assange assisted suicide asylum asylum seekers Australia autism badgers benefits Bill of Rights biotechnology blogging Bloody Sunday brexit Bribery British Waterways Board care homes Catholic Church Catholicism Chagos Islanders Charter of Fundamental Rights child protection Children children's rights China christianity citizenship civil liberties campaigners civil partnerships climate change clinical negligence closed material procedure Coercion Commission on a Bill of Rights common law communications competition confidentiality consent conservation constitution contact order contact tracing contempt of court Control orders Copyright coronavirus coronavirus act 2020 costs costs budgets Court of Protection covid crime criminal law Cybersecurity Damages data protection death penalty defamation DEFRA deportation deprivation of liberty derogations Detention Dignitas diplomacy diplomatic relations disability disclosure Discrimination disease divorce DNA domestic violence duty of care ECHR ECtHR Education election Employment Environment Equality Act Equality Act 2010 Ethiopia EU EU Charter of Fundamental Rights EU costs EU law European Convention on Human Rights European Court of Human Rights European Court of Justice evidence extradition extraordinary rendition Facebook Facial Recognition Family Fatal Accidents Fertility FGM Finance foreign criminals foreign office foreign policy France freedom of assembly Freedom of Expression freedom of information freedom of speech Gay marriage gay rights Gaza Gender genetics Germany Google Grenfell Gun Control hague convention Harry Dunn Health HIV home office Housing HRLA human rights Human Rights Act human rights news Human Rights Watch Huntington's Disease immigration India Indonesia injunction Inquests insurance international law internet inuit Iran Iraq Ireland islam Israel Italy IVF ivory ban Japan joint enterprise judaism judicial review Judicial Review reform Julian Assange jury trial JUSTICE Justice and Security Bill Law Pod UK legal aid legal aid cuts Leveson Inquiry lgbtq liability Libel Liberty Libya lisbon treaty Lithuania local authorities marriage Media and Censorship mental capacity Mental Capacity Act Mental Health military Ministry of Justice modern slavery morocco murder music Muslim nationality national security naturism neuroscience NHS Northern Ireland nuclear challenges nuisance Obituary ouster clauses parental rights parliamentary expenses scandal patents Pensions Personal Injury physician assisted death Piracy Plagiarism planning planning system Poland Police Politics Pope press prison Prisoners prisoner votes Prisons privacy procurement Professional Discipline Property proportionality prosecutions prostituton Protection of Freedoms Bill Protest Public/Private public access public authorities public inquiries quarantine Radicalisation refugee rehabilitation Reith Lectures Religion RightsInfo right to die right to family life Right to Privacy right to swim riots Roma Romania round-up Round Up Royals Russia saudi arabia Scotland secrecy secret justice Secret trials sexual offence shamima begum Sikhism Smoking social media social workers South Africa Spain special advocates Sports Standing starvation statelessness stem cells stop and search Strasbourg super injunctions Supreme Court Supreme Court of Canada surrogacy surveillance sweatshops Syria Tax technology Terrorism The Round Up tort Torture travel treason treaty accession trial by jury TTIP Turkey Twitter UK Ukraine universal credit universal jurisdiction unlawful detention USA US Supreme Court vicarious liability Wales War Crimes Wars Weekly Round-up Welfare Western Sahara Whistleblowing Wikileaks wildlife wind farms WomenInLaw Worboys wrongful birth YearInReview Zimbabwe


This blog is maintained for information purposes only. It is not intended to be a source of legal advice and must not be relied upon as such. Blog posts reflect the views and opinions of their individual authors, not of chambers as a whole.

Our privacy policy can be found on our ‘subscribe’ page or by clicking here.

%d bloggers like this: